Peripheral Neuropathy with Nucleoside Antiretrovirals: Risk Factors, Incidence and Management

ISSN： 0114-5916

Source： Drug Safety, Vol.19, Iss.6, 1998-12, pp. : 481-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatotoxicity of Antiretrovirals: Incidence, Mechanisms and Management

By Marina Núñez Vincent Soriano

Drug Safety, Vol. 28, Iss. 1, 2005-01 ,pp. : 53-66

Adis International

Access to resources Recommend Favorite

Targeted Delivery of Growth Factors by HSV-Mediated Gene Transfer for Peripheral Neuropathy

Current Gene Therapy, Vol. 13, Iss. 5, 2013-01 ,pp. : 315-321

Bentham Science Publishers

Access to resources Recommend Favorite

Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

By Gaist David García Rodríguez Luis Alberto Huerta Consuelo Hallas Jesper Sindrup Søren H.

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 931-933

Springer Publishing Company

Access to resources Recommend Favorite

Antiretrovirals: low risk in pregnancy

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

A review of incidence and relevant risk factors in genitourinary malignancies

By Tobin Marie B. Steinberg Gary D.

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1731-1734

Blackwell Publishing

Access to resources Recommend Favorite